| D00095 |
Epinephrine (USP/INN); Adrenaline (JP19); Auvi-q (TN); Epipen (TN) |
(CI) Target: ADRA1A ADRA1B ADRA1D ADRB1 |
| D00107 |
Tacrolimus (USP/INN); Tacrolimus hydrate (JP19); Prograf (TN); Protopic (TN) |
(P) Enzyme: CYP3A4 |
| D00184 |
Cyclosporine (USP); Ciclosporin (JP19); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00186 |
Ciprofloxacin (JP19/USP/INN); Cipro (TN); Otiprio (TN) |
(P) unclassified |
| D00203 |
Amphotericin B (JP19/USP/INN); Ambisome (TN); Amphotec (TN); Fungizone (TN) |
(P) unclassified |
| D00211 |
Rifampin (USP); Rifampicin (JP19/INN); Rifadin (TN); Rimactane (TN) |
(P) CYP induction: CYP3A4 |
| D00228 |
Amoxapine (JP19/USP/INN); Asendin (TN) |
(P) unclassified |
| D00235 |
Atenolol (JP19/USP/INN); Tenormin (TN) |
(P) Target: ADRB1 |
| D00255 |
Carvedilol (JP19/USP/INN); Artist (TN); Coreg (TN) |
(P) Enzyme: CYP3A4 / Target: ADRA1A ADRA1B ADRA1D ADRB1 |
| D00283 |
Clozapine (JAN/USP/INN); Clozaril (TN) |
(CI) Enzyme: CYP3A4 |
| D00292 |
Dexamethasone (JP19/USP/INN); Decadron (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00293 |
Diazepam (JP19/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP3A4 |
| D00295 |
Cimetidine (JP19/USP/INN); Tagamet (TN) |
(P) CYP inhibition: CYP3A4 |
| D00298 |
Digoxin (JP19/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) unclassified |
| D00320 |
Fentanyl (JAN/USP/INN); Duragesic (TN); Subsys (TN) |
(P) Enzyme: CYP3A4 |
| D00346 |
Isoniazid (JP19/USP/INN); Laniazid (TN) |
(P) unclassified |
| D00358 |
Lidocaine (JP19/USP/INN); Dentipatch (TN); Xylocaine (TN) |
(P) Enzyme: CYP3A4 / Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D00371 |
Theophylline (JP19); Elixophyllin (TN); Quibron-t (TN); Theo-24 (TN); Theodur G (TN); Theolair (TN); Uniphyl (TN) |
(P) unclassified |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
| D00432 |
Nadolol (JP19/USP/INN); Corgard (TN) |
(P) Target: ADRB1 |
| D00434 |
Simvastatin (JP19/USP/INN); MK-733; Zocor (TN) |
(P) Enzyme: CYP3A4 |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) Enzyme: CYP3A4 |
| D00478 |
Procarbazine hydrochloride (JP19/USP); Matulane (TN) |
(P) unclassified |
| D00483 |
Propranolol hydrochloride (JP19/USP); Inderal (TN); Innopran XL (TN) |
(P) Target: ADRB1 |
| D00506 |
Phenobarbital (JP19/USP/INN); Luminal (TN) |
(P) unclassified |
| D00512 |
Phenytoin (JP19/USP/INN); Dilantin (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D00528 |
Caffeine (USP); Anhydrous caffeine (JP19); Anhydrous caffeine (TN); Respia (TN) |
(P) unclassified |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) Enzyme: CYP3A4 |
| D00600 |
Labetalol hydrochloride (JP19/USP); Normodyne (TN); Trandate (TN) |
(P) Target: ADRA1A ADRA1B ADRA1D ADRB1 |
| D00601 |
Metoprolol tartrate (JP19/USP); Lopressor (TN) |
(P) Target: ADRB1 |
| D00616 |
Diltiazem hydrochloride (JP19/USP); Cardizem (TN); Cartia XT (TN); Dilacor XR (TN); Dilt-CD (TN) |
(P) Enzyme: CYP3A4 |
| D00619 |
Verapamil hydrochloride (JP19/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00634 |
Bisoprolol fumarate (JP19/USP); Zebeta (TN) |
(P) Target: ADRB1 |
| D00636 |
Amiodarone hydrochloride (JP19/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(CI,P) Enzyme: CYP3A4 / Target: ADRA1A ADRA1B ADRA1D ADRB1 KCND3 KCNH2 KCNJ11 KCNJ12 KCNJ3 KCNJ5 KCNJ8 KCNQ1 SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D00639 |
Mexiletine hydrochloride (JP19/USP); Mexitil (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D00644 |
Esmolol hydrochloride (JAN/USP); Brevibloc (TN) |
(P) Target: ADRB1 |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00738 |
Mepivacaine hydrochloride (JP19/USP); Carbocaine (TN); Polocaine (TN); Scandonest plain (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D00765 |
Rocuronium bromide (JAN/USP/INN); Zemuron (TN) |
(P) unclassified |
| D00776 |
Tizanidine hydrochloride (JP19/USP); Zanaflex (TN) |
(P) unclassified |
| D00780 |
Bromocriptine mesylate (USP); Bromocriptine mesilate (JP19); Parlodel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00785 |
Selegiline hydrochloride (JAN/USP); Eldepryl (TN) |
(P) Enzyme: CYP3A4 |
| D00809 |
Amitriptyline hydrochloride (JP19/USP); Elavil (TN) |
(P) Enzyme: CYP3A4 |
| D00811 |
Clomipramine hydrochloride (JP19/USP); Anafranil (TN) |
(P) Enzyme: CYP3A4 |
| D00815 |
Imipramine hydrochloride (JP19/USP); Tofranil (TN) |
(P) Enzyme: CYP3A4 |
| D00816 |
Nortriptyline hydrochloride (JP19/USP/INN); Pamelor (TN) |
(P) unclassified |
| D00818 |
Maprotiline hydrochloride (JP19/USP); Ludiomil (TN) |
(P) unclassified |
| D00831 |
Mefloquine hydrochloride (JP19/USP); Lariam (TN) |
(P) unclassified |
| D00834 |
Pentamidine isethionate (USP); Pentamidine isetionate (JAN); Pentamidine diisethionate; Pentam 300 (TN) |
(CI) unclassified |
| D00848 |
Dextromethorphan hydrobromide (USP); Dextromethorphan hydrobromide hydrate (JP19); Benylin DM (TN) |
(P) unclassified |
| D00874 |
Moxifloxacin hydrochloride (JAN/USP); Avelox (TN); Vigamox (TN) |
(CI) unclassified |
| D00947 |
Linezolid (JAN/USAN/INN); Zyvox (TN) |
(P) unclassified |
| D00961 |
Bicalutamide (JP19/USP/INN); Casodex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00967 |
Toremifene citrate (JAN/USAN); Fareston (TN) |
(CI) Enzyme: CYP3A4 |
| D00999 |
Acetylcholine chloride (JP19/USP/INN); Miochol (TN) |
(P) unclassified |
| D01010 |
Levothyroxine sodium (USP); Levothyroxine sodium hydrate (JP19); Levothroid (TN); Levoxyl (TN); Synthroid (TN) |
(P) unclassified |
| D01011 |
Liothyronine sodium (JP19/USP); Cytomel (TN); Triostat (TN) |
(P) unclassified |
| D01026 |
Sotalol hydrochloride (JAN/USP); Betapace (TN); Sorine (TN) |
(P) Target: ADRB1 KCNH2 |
| D01179 |
Duloxetine hydrochloride (JAN/USP); Cymbalta (TN); Yentreve (TN) |
(P) unclassified |
| D01240 |
Deslanoside (JP19/USP/INN); Cedilanid-d (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP3A4 |
| D01263 |
Ritodrine hydrochloride (JP19/USP); Yutopar (TN) |
(P) unclassified |
| D01280 |
Warfarin potassium (JP19); Athrombin-K (TN) |
(P) unclassified |
| D01287 |
Levobupivacaine hydrochloride (JAN/USAN); Chirocaine (TN) |
(P) Enzyme: CYP3A4 / Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D01369 |
Bevantolol hydrochloride (JAN/USAN); Calvan (TN); Vantol (TN) |
(P) Target: ADRA1A ADRA1B ADRA1D ADRB1 |
| D01390 |
Isoproterenol hydrochloride (USP); dl-Isoprenaline hydrochloride (JAN); Isuprel (TN); Proternol-S (TN) |
(P) Target: ADRB1 |
| D01399 |
Fentanyl citrate (JP19/USP); Abstral (TN); Fentora (TN); Lazanda (TN); Oralet (TN) |
(P) Enzyme: CYP3A4 |
| D01450 |
Bupivacaine hydrochloride (USP); Bupivacaine hydrochloride hydrate (JP19); Marcaine (TN) |
(P) Enzyme: CYP3A4 / Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D01710 |
Roxithromycin (JP19/USAN/INN); Rulide (TN) |
(P) unclassified |
| D01748 |
Isoxsuprine hydrochloride (JP19/USP); Duvadilan (TN) |
(P) unclassified |
| D01785 |
Pirmenol hydrochloride hydrate (JAN) |
(CI) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D01830 |
Arotinolol hydrochloride (JP19); Almarl (TN) |
(P) Target: ADRA1A ADRA1B ADRA1D ADRB1 |
| D01847 |
Landiolol hydrochloride (JAN/USAN); ONO 1101 hydrochloride; Onoact (TN); Rapiblyk (TN) |
(P) Target: ADRB1 |
| D01856 |
Nifekalant hydrochloride (JAN); MS 551; Shinbit (TN) |
(P) Target: KCND3 KCNH2 KCNJ12 |
| D01872 |
Doxapram hydrochloride (USP); Doxapram hydrochloride hydrate (JP19); Dopram (TN) |
(P) Enzyme: CYP3A4 |
| D02009 |
Erythromycin lactobionate (JP19/USP); Erythrocin (TN) |
(CI) unclassified |
| D02086 |
Lidocaine hydrochloride (JAN/USP); Dalcaine (TN); Xylocaine (TN) |
(P) Enzyme: CYP3A4 / Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D02102 |
Methadone hydrochloride (JAN/USP); Dolophine hydrochloride (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP19); Aleviatin (TN); Dilantin (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D02106 |
Arsenic trioxide (JP19/USAN); Trisenox (TN) |
(P) unclassified |
| D02114 |
Hydroxychloroquine sulfate (JAN/USP); Plaquenil (TN) |
(P) Enzyme: CYP3A4 |
| D02126 |
Primaquine phosphate (JAN/USP) |
(P) unclassified |
| D02150 |
l-Isoprenaline hydrochloride (JP19); Proternol-L (TN) |
(P) Target: ADRB1 |
| D02216 |
Ciprofloxacin hydrochloride (USP); Ciprofloxacin hydrochloride hydrate (JP19); Ciloxan (TN); Cipro (TN); Proquin XR (TN) |
(P) unclassified |
| D02260 |
Paroxetine hydrochloride hemihydrate (USP); Paroxetine hydrochloride hydrate (JP19); Paxil (TN) |
(P) unclassified |
| D02342 |
Bisoprolol (JAN/USAN/INN) |
(P) Target: ADRB1 |
| D02372 |
Perospirone hydrochloride hydrate (JP19); Lullan (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02540 |
Garenoxacin mesylate (USAN); Garenoxacin mesilate hydrate (JAN) |
(P) unclassified |
| D02562 |
Rasagiline mesylate (USAN); Rasagiline mesilate (JAN); Azilect (TN) |
(P) unclassified |
| D02567 |
Escitalopram oxalate (JAN/USP); Lexapro (TN) |
(P) Enzyme: CYP3A4 |
| D02574 |
Atomoxetine hydrochloride (JAN/USP); Tomoxetine hydrochloride; Strattera (TN) |
(P) unclassified |
| D02587 |
Metildigoxin (JP19); Lanirapid (TN) |
(P) unclassified |
| D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) unclassified |
| D02732 |
Pranlukast hydrate (JP19); Onon (TN) |
(P) Enzyme: CYP3A4 |
| D02740 |
Lidocaine and prilocaine; Lidocaine and propitocaine; Emla (TN); Oraqix (TN) |
(P) Enzyme: CYP3A4 |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
| D03260 |
Vardenafil hydrochloride hydrate (JAN); Vardenafil monohydrochloride trihydrate; Levitra (TN); Staxyn (TN) |
(CI) Enzyme: CYP3A4 |
| D03365 |
Nicotine (USP); Habitrol (TN) |
(P) unclassified |
| D03658 |
Dasatinib (JAN/INN) |
(P) Enzyme: CYP3A4 |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP induction: CYP3A4 |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) Enzyme: CYP3A4 |
| D04048 |
Ropivacaine hydrochloride (USP); Ropivacaine hydrochloride hydrate (JAN); Anapeine (TN) |
(P) Enzyme: CYP3A4 / Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D04052 |
Epinephrine and lidocaine hydrochloride; Adrenaline and lidocaine hydrochloride; Xylocaine (TN) |
(CI,P) Enzyme: CYP3A4 |
| D04187 |
Fingolimod hydrochloride (JAN/USAN); Gilenya (TN) |
(CI) unclassified |
| D04340 |
Dextromethorphan hydrobromide and potassium cresolsulfonate; Medicon (TN) |
(P) Enzyme: CYP3A4 |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) unclassified |
| D04813 |
Lidocaine hydrochloride and epinephrine bitartrate; Lidocaine hydrochloride and adrenaline bitartrate; Ora (TN); Lidosite (TN) |
(P) Enzyme: CYP3A4 |
| D04817 |
Propitocaine hydrochloride and felypressin; Citanest octapressin (TN) |
(P) unclassified |
| D05037 |
Trimetoquinol hydrochloride hydrate (JP19); Tretoquinol hydrate; Caluyon (TN) |
(P) unclassified |
| D05277 |
Formoterol fumarate hydrate (JP19); Formoterol fumarate dihydrate; Atock (TN); Foradil (TN) |
(P) unclassified |
| D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(P) unclassified |
| D05429 |
Aminophylline hydrate (JP19) |
(P) unclassified |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D05908 |
Spiramycin (JAN/USAN/INN); Rovamycin (TN) |
(P) unclassified |
| D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(P) Enzyme: CYP3A4 |
| D06407 |
Vandetanib (JAN/USAN/INN); Caprelsa (TN) |
(P) Enzyme: CYP3A4 |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) Enzyme: CYP3A4 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) Enzyme: CYP3A4 |
| D06478 |
Darunavir ethanolate (JAN); Prezista (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D06637 |
Romidepsin (JAN/USAN/INN); Istodax (TN) |
(P) unclassified |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) unclassified |
| D07585 |
Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine; Cleamine A (TN) |
(P) Enzyme: CYP3A4 |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A / CYP induction: CYP3A4 |
| D07682 |
Clazosentan sodium (JAN/USAN); Pivlaz (TN) |
(P) unclassified |
| D08095 |
Ivabradine hydrochloride (JAN/USAN); Ivabrandine hydrochloride; Corlanor (TN); Corlentor (TN); Coralan (TN) |
(P) Enzyme: CYP3A4 |
| D08127 |
Lidocaine hydrochloride monohydrate; Lidocaine (TN); Zingo (TN) |
(P) Enzyme: CYP3A4 / Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D08856 |
Anamorelin hydrochloride (JAN/USAN); Adlumiz (TN) |
(P) Enzyme: CYP3A4 |
| D09319 |
Indacaterol maleate (JAN/USAN); Arcapta (TN) |
(P) Enzyme: CYP3A4 |
| D09595 |
Budesonide and formoterol fumarate dihydrate; Symbicort (TN); Budeforu (TN) |
(P) Enzyme: CYP3A4 |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) Enzyme: CYP3A4 |
| D09720 |
Rilpivirine (JAN/USAN/INN); Rekambys (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) Enzyme: CYP3A4 |
| D09756 |
Teneligliptin hydrobromide hydrate (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09783 |
Tofacitinib citrate (JAN/USAN); Tasocitinib citrate; Xeljanz (TN) |
(P) Enzyme: CYP3A4 |
| D09785 |
Delamanid (JAN/USAN); Deltyba (TN) |
(P) Enzyme: CYP3A4 |
| D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) CYP inhibition: CYP3A4 |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(CI) unclassified |
| D09920 |
Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN); Lenvima (TN) |
(P) unclassified |
| D09958 |
Rilpivirine hydrochloride (JAN/USAN); Edurant (TN) |
(P) unclassified |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP induction: CYP3A4 |
| D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) CYP induction: CYP3A4 |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10127 |
Glycerol phenylbutyrate (JAN/USAN); Ravicti (TN) |
(P) unclassified |
| D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
| D10191 |
Safinamide mesylate (USAN); Safinamide mesilate (JAN); Safinamide methanesulfonate; Xadago (TN); Equfina (TN) |
(P) unclassified |
| D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
| D10223 |
Ibrutinib (JAN/USAN); Imbruvica (TN) |
(P) unclassified |
| D10252 |
Fexofenadine hydrochloride and pseudoephedrine hydrochloride; Allegra-d (TN) |
(P) unclassified |
| D10255 |
Anagrelide hydrochloride hydrate (JAN); Anagrelide hydrochloride monohydrate; Agrylin (TN) |
(P) unclassified |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP3A4 |
| D10501 |
Fluticasone furoate and vilanterol trifenatate; Breo ellipta (TN); Relvar ellipita (TN) |
(P) Enzyme: CYP3A4 |
| D10505 |
Glycopyrronium bromide and indacaterol maleate; Ultibro (TN) |
(P) Enzyme: CYP3A4 |
| D10506 |
Fluticasone propionate and formoterol fumarate hydrate; Flutiform (TN) |
(P) Enzyme: CYP3A4 |
| D10533 |
Umeclidinium bromide and vilanterol; Anoro (TN) |
(P) Enzyme: CYP3A4 |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
| D10578 |
Ledipasvir and sofosbuvir; Harvoni (TN) |
(P) unclassified |
| D10633 |
Finerenone (JAN/USAN/INN); Kerendia (TN) |
(P) Enzyme: CYP3A4 |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10744 |
Tiotropium and olodaterol; Spiolto (TN) |
(P) unclassified |
| D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
| D10772 |
Lascufloxacin hydrochloride (JAN); Lasvic (TN) |
(CI,P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP3A4 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) unclassified |
| D10827 |
Sofosbuvir and velpatasvir; Epclusa (TN) |
(P) Enzyme: CYP3A4 |
| D10832 |
Darunavir and cobicistat; Prezcobix (TN); Rezolsta (TN) |
(P) unclassified |
| D10836 |
Emtricitabine, rilpivirine and tenofovir alafenamide; Odefsey (TN) |
(P) unclassified |
| D10897 |
Teneligliptin and canagliflozin; Teneligliptin and canagliflozin; Canalia (TN) |
(P) Enzyme: CYP3A4 |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) Enzyme: CYP3A4 |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) Enzyme: CYP3A4 |
| D10931 |
Etrasimod arginine (USAN); Etrasimod L-arginine (JAN); Velsipity (TN) |
(P) Enzyme: CYP3A4 |
| D10967 |
Ozanimod hydrochloride (JAN/USAN); Zeposia (TN) |
(P) unclassified |
| D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
| D10993 |
Tucidinostat (JAN/USAN/INN); Hiyasta (TN) |
(P) unclassified |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11035 |
Fluticasone furoate, umeclidinium bromide and vilanterol; Trelegy ellipta (TN) |
(P) unclassified |
| D11036 |
Glycopyrrolate and formoterol; Bevespi (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) Enzyme: CYP3A4 |
| D11062 |
Osilodrostat phosphate (JAN/USAN); Isturisa (TN) |
(P) Enzyme: CYP3A4 |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(CI) unclassified |
| D11090 |
Ivosidenib (JAN/USAN/INN); Tibsovo (TN) |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
| D11290 |
Articaine hydrochloride and epinephrine; Articaine hydrochloride and adrenaline; Orabloc (TN); Septocaine (TN); Ultacan (TN) |
(P) unclassified |
| D11296 |
Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN); Fedratinib dihydrochloride monohydrate; Inrebic (TN) |
(P) Enzyme: CYP3A4 |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) unclassified |
| D11382 |
Darunavir, cobicistat, emtricitabine and tenofovir alafenamide; Symtuza (TN) |
(P) unclassified |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(P) unclassified |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(P) Enzyme: CYP3A4 |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11557 |
Tecovirimat hydrate (JAN); Tecovirimat monohydrate; Tpoxx (TN); Tepoxx (TN) |
(P) unclassified |
| D11584 |
Budesonide, glycopyrronium bromide and formoterol fumarate; Budesonide, glycopyrrolate and formoterol fumarate; Breztri (TN) |
(P) unclassified |
| D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) Enzyme: CYP3A4 |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11816 |
Belumosudil mesylate (USAN); Belumosudil mesilate (JAN); Rezurock (TN) |
(P) Enzyme: CYP3A4 |
| D11835 |
Vorasidenib citrate (USAN); Vorasidenib citric acid hydrate (JAN); Voranigo (TN) |
(P) unclassified |
| D11861 |
Indacaterol acetate, glycopyrronium bromide and mometasone furoate; Enerzair (TN) |
(P) unclassified |
| D11862 |
Indacaterol and mometasone furoate; Atectura (TN) |
(P) unclassified |
| D11887 |
Daridorexant hydrochloride (JAN/USAN); Quviviq (TN) |
(P) unclassified |
| D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
| D11954 |
Belzutifan (JAN/USAN/INN); Welireg (TN) |
(P) unclassified |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) unclassified |
| D12050 |
Pirtobrutinib (JAN/USAN); Jaypirca (TN) |
(P) Enzyme: CYP3A4 |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12245 |
Lazertinib mesylate (USAN); Lazertinib mesilate hydrate (JAN); Lazcluze (TN) |
(P) Enzyme: CYP3A4 |
| D12252 |
Iptacopan hydrochloride (USAN); Iptacopan hydrochloride hydrate (JAN); Iptacopan hydrochloride monohydrate; Fabhalta (TN) |
(P) CYP induction: CYP3A4 |
| D12442 |
Tucatinib ethanolate (JAN); Tucatinib hemiethanolate; Tukysa (TN) |
(P) unclassified |
| D12444 |
Nilotinib hydrochloride dihydrate (JAN) |
(P) Enzyme: CYP3A4 |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
| D12837 |
Risovalisib mesilate hydrate (JAN); Risovalisib mesylate dihydrate; Haizexin (TN) |
(P) unclassified |
